Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Latest filing published 14 Jun 2022 for Neogenomics INC.
Filing timeline
BuySaleDavid Daly
Insider track record
Disclosed buys
0
Disclosed sells
31
Signal history
David Daly: trading record in brief
David Daly (board member) discloses dealings in 3 companies, chiefly Foundation Medicine, Inc., Clarient, Inc and Neogenomics Inc. The record holds 42 filings, for trades running from 30 January 2008 to 10 June 2022.
Sales make up the whole of the open-market record (31 sales, €2.3M). The rest of the record consists of 8 share grants and 1 option exercise.
The record was last updated on 14 June 2022 with a share grant in Neogenomics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Daly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations42 total
15,556 shares0Common StockSEC:0001077183-22-000108:0
1,623 shares0Common StockSEC:0001077183-21-000247:0
46,872 shares@ US$22.2417.9% of flowCommon StockSEC:0001209191-17-048408:0
46,872 shares@ US$39.5031.8% of flowCommon StockSEC:0001209191-17-048408:1
2,829 shares@ US$38.841.9% of flowCommon StockSEC:0001209191-17-044354:0
2,452 shares@ US$38.841.7% of flowCommon StockSEC:0001209191-17-044354:1
1,035 shares@ US$38.840.7% of flowCommon StockSEC:0001209191-17-044354:2
555 shares@ US$38.300.4% of flowCommon StockSEC:0001209191-17-037656:0
24,550 shares@ US$35.8016.3% of flowCommon StockSEC:0001209191-17-029595:0
2,070 shares@ US$31.961.3% of flowCommon StockSEC:0001209191-17-025569:0
541 shares@ US$25.120.3% of flowCommon StockSEC:0001209191-17-017389:0
2,727 shares@ US$17.410.9% of flowCommon StockSEC:0001209191-17-001959:0
2,370 shares@ US$18.490.8% of flowCommon StockSEC:0001209191-17-001959:1
564 shares@ US$19.950.2% of flowCommon StockSEC:0001209191-16-153308:0
2,045 shares@ US$23.650.9% of flowCommon StockSEC:0001209191-16-144862:0
551 shares@ US$20.480.2% of flowCommon StockSEC:0001209191-16-140050:0
2,878 shares@ US$17.390.9% of flowCommon StockSEC:0001209191-16-131501:0
2,130 shares@ US$18.260.7% of flowCommon StockSEC:0001209191-16-131501:1
472 shares@ US$21.660.2% of flowCommon StockSEC:0001209191-16-126245:0
70,000 shares@ US$18.2522.7% of flowCommon StockSEC:0001209191-16-113428:0
701 shares@ US$15.140.2% of flowCommon StockSEC:0001209191-16-105257:0
2,559 shares@ US$16.78Common StockSEC:0001209191-15-083188:0
23,190 shares@ US$32.74Common StockSEC:0001209191-15-061484:0
25,000 shares@ US$22.24Common StockSEC:0001209191-14-073733:0
158,334 shares@ US$5.00Clarient, Inc. common stockSEC:0001179110-10-018104:0
25 of 42 declarations
